Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide

ABSTRACT:

SUBMITTER: Augustin R 

PROVIDER: S-EPMC12311552 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature